CIRM October Meeting: Disease Teams, Biotech Loan Program and New Stem Cell Lines
Directors of the California stem cell agency always seem to have more than they can do in their meetings, and October's seems to be no exception.
Creation of a new $122 million disease team effort and a biotech loan program (see above) that could give CIRM life in perpetuity are among the matters to be discussed in San Diego at the Oct. 3 meeting of the
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.